Daxdilimab [2245966-28-1]

TargetMol Chemicals

Daxdilimab

9

2245966-28-1

Antibody

Research Use Only

Daxdilimab

Daxdilimab, an anti-ILT7 monoclonal antibody, targets the ILT7 cell surface molecule exclusive to pDC dendritic cells. It shows potential for treating acute lung injury (ALI) in COVID-19 infected patients, as indicated in research [1] [2].

3 years

-20°C

12352203